Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
Condition:   Gastroesophageal Reflux DiseaseInterventions:   Drug: Dexlansoprazole 30 mg;   Drug: Dexlansoprazole 60 mgSponsor:   TakedaNot yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2015 Category: Research Source Type: clinical trials

Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
Condition:   Gastroesophageal Reflux DiseaseInterventions:   Drug: Dexlansoprazole 30 mg;   Drug: Dexlansoprazole 60 mgSponsor:   TakedaRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2015 Category: Research Source Type: clinical trials

Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
Condition:   Gastroesophageal Reflux DiseaseInterventions:   Drug: Dexlansoprazole 30 mg;   Drug: Dexlansoprazole 60 mgSponsor:   TakedaNot yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2015 Category: Research Source Type: clinical trials

Dexlansoprazole MR in Nonerosive Reflux Disease
Condition:   Nonerosive Reflux DiseaseIntervention:   Drug: Dexlansoprazole MRSponsor:   Soonchunhyang University HospitalEnrolling by invitation - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2014 Category: Research Source Type: clinical trials